SARAH WOODRICK: Open Payments
NPI 1467909697 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,590 in 78 payments from 17 companies in 2025. Trend: 2023 $969 · 2024 $853 · 2025 $1,590
Food & beverage: $1,430Education: $160
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 13 | $364 |
| ABBVIE INC. | 21 | $201 |
| UCB, Inc. | 8 | $168 |
| Janssen Biotech, Inc. | 2 | $121 |
| Mallinckrodt Hospital Products Inc. | 3 | $119 |
| Novartis Pharmaceuticals Corporation | 7 | $117 |
| Regeneron Healthcare Solutions, Inc. | 4 | $98 |
| Incyte Corporation | 3 | $85 |
| LEO Pharma Inc. | 4 | $74 |
| Genentech USA, Inc. | 2 | $59 |
Products named: NEMLUVIO, Bimzelx, DUPIXENT, TREMFYA, ACTHAR, RINVOQ, OPZELURA, SKYRIZI.
Industry payments across IN — which companies pay providers there.
